Skip to content

Announcements

Secondary Progressive MS treatment fast-tracked for FDA Approval
avatar
hackwriter posted:
Opexa has changed the name of its drug, Tovaxin, to Tcelna, as it relaunches Phase IIb trials in 2012 in SPMS patients. See details in the link below:

http://www.opexatherapeutics.com/?page=tovaxin&section=tovaxin

Currently there is only one FDA-approved treatment for SPMS. Novantrone, originally a cancer chemotherapy, is an infusion therapy performed once every three months for up to 24 months for the treatment of Secondary-Progressive MS.
Was this Helpful?
2 of 3 found this helpful
Reply


Featuring Experts

Stephanie knows multiple sclerosis as a patient and as a nurse. Stephanie was diagnosed with multiple sclerosis in 2013. Shortly after being diagnosed...More

Helpful Tips

Tip for hives
My daughter suffers with hives, they have never found out what causes her hives either. We thought since I was recently diagnosed that ... More
Was this Helpful?
1 of 1 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.